Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine

Immunology Letters

Volumn 64, Issue 1, 1998, Pages 9-15

  Ben Yedidia, T ^a   Arnon, R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Carrier; Epitope; Influenza; Suppression; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VIRUS; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHI; VACCINATION;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FLAGELLIN; INFLUENZA VACCINES; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; SALMONELLA TYPHI; TIME FACTORS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0032441847     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00073-X     Document Type: Article

References (21)

1. A.R. Lussow, M.T. Aguado, G.G. Del, P.H. Lambert, Immunol. Lett. 25 (1990) 255-263.
2. L.A. Herzenberg, T. Tokuhisa, K. Hayakawa, Ann. Rev. Immunol. 1 (1983) 609-632.
3. D.A. Herrington, D.F. Clyde, J.R. Davis, S. Baqar, J.R. Murphy, J.F. Cortese, R.S. Bank, E. Nardin, D. DiJohn, R.S. Nussenzweig, et al., Bull. WHO (1990), 68, pp. 33-37.
4. J.M. Lieberman, D.P. Greenberg, V.K. Wong, S. Partridge, S.J. Chang, C.Y. Chiu, J.I. Ward, J. Pediatr. 126 (1995) 198-205.
5. T. Barington, M. Skettrup, L. Juul, C. Heilmann, Infect. Immun. 61 (1993) 432-438.
6. J.D. Di, S.S. Wasserman, J.R. Torres, M.J. Cortesia, J. Murillo, G.A. Losonsky, D.A. Herrington, D. Sturcher, M.M. Levine, Lancet 2 (1989) 1415-1418.
7. A. Kaliyaperumal, V.S. Chauhan, G.P. Talwar, R. Raghupathy, Eur. J. Immunol. 25 (1995) 3375-3380.
8. C.O. Jacob, R. Arnon, M. Sela, Mol. Immunol. 22 (1985) 1333-1339.
9. F.R. Vogel, C. Leclerc, M.P. Schutze, M. Jolivet, F. Audibert, T.W. Klein, L. Chedid, Cell. Immunol. 107 (1987) 40-51.
10. J.A. Chabalgoity, Villareal, B. Ramos, C.M. Khan, S.N. Chatfield, R.D. de Hormaeche, C.E. Hormaeche, Infect. Immun. 63 (1995) 2564-2569.
11. L.D. Lise, D. Mazier, M. Jolivet, F. Audibert, L. Chedid, D. Schlesinger, Infect. Immun. 55 (1987) 2658-2661.
12. H.M. Etlinger, D. Gillessen, H.W. Lahm, H. Matile, H.J. Schonfeld, A. Trzeciak, Science 249 (1990) 423-425.
13. M.P. Schutze, C. Leclerc, F.R. Vogel, L. Chedid, Cell. Immunol. 104 (1987) 79-90.
14. R. Levi, R. Arnon, Vaccine 14 (1996) 85-92.
15. R. Levi, R. Arnon, in: R.M. Chanock, F. Brown, H. Ginsberg, E. Norrby (Eds.), Vaccine, CSHL Press, New York, 1995, pp. 311-316.
16. S.M.C. Newton, C.O. Jacob, B.A.D. Stocker, Science 244 (1989) 70-72.
17. J. McEwen, R. Levi, R.J. Horwitz, R. Arnon, Vaccine 10 (1992) 405-411.
18. G.F. Ibrahim, G.H. Fleet, M.L. Lyons, R.A. Walter, J. Clin. Microbiol. 22 (1985) 1040-1044.
19. T. Barrett, S.C. Inglis, in: W.J. Mahy (Ed.), Virology: A Practical Approach, IRL Press, Washington, D.C., 1985, pp. 119-151.
20. T. Ben-Yedidia, L. Abel, R. Arnon, A. Globerson, Mech. Ageing Devel. 104 (1998) 11-23.
21. C. Fayolle, E. Deriaud, C. Leclerc, J. Immunol. 147 (1991) 4069-4073.